KEROS THERAPEUTICS INC. - COMMON STOCK

Keros Therapeutics to Present at the Jefferies Virtual Healthcare Conference

27 5 2021 08:00:01 提供 Nasdaq GlobeNewswire

Keros Therapeutics Announces Issuance of U.S. Patent for Use of Therapeutic Proteins in Treatment of Musculoskeletal Disorders

25 5 2021 08:00:05 提供 Nasdaq GlobeNewswire

Keros Therapeutics Presents Results from Preclinical Study of KER-012 in Pulmonary Arterial Hypertension at the American Thoracic Society International Conference

14 5 2021 08:00:00 提供 Nasdaq GlobeNewswire

Keros Therapeutics to Present at the Virtual 26th Annual Congress of the European Hematology Association

12 5 2021 16:01:00 提供 Nasdaq GlobeNewswire

Keros Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results

06 5 2021 16:01:02 提供 Nasdaq GlobeNewswire

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

25 3 2021 08:00:01 提供 Nasdaq GlobeNewswire

Keros Therapeutics Presents Results from Preclinical Studies of KER-050 and ALK2 Inhibitors at the European School of Haematology (ESH) 2nd Translational Research E-Conference

05 3 2021 08:00:00 提供 Nasdaq GlobeNewswire

Keros Therapeutics to Present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference

02 3 2021 08:00:02 提供 Nasdaq GlobeNewswire

Keros Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

17 2 2021 08:00:01 提供 Nasdaq GlobeNewswire